| CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment SY Neo, Y Yang, J Record, R Ma, X Chen, Z Chen, NP Tobin, E Blake, ... The Journal of clinical investigation 130 (3), 1185-1198, 2020 | 175 | 2020 |
| Current applications of antibody microarrays Z Chen, T Dodig-Crnković, JM Schwenk, S Tao Clinical proteomics 15, 1-15, 2018 | 101 | 2018 |
| Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells Y Yang, SY Neo, Z Chen, W Cui, Y Chen, M Guo, Y Wang, H Xu, A Kurzay, ... The Journal of Clinical Investigation 130 (10), 5508-5522, 2020 | 68 | 2020 |
| Strategies to augment natural killer (NK) cell activity against solid tumors Z Chen, Y Yang, LL Liu, A Lundqvist Cancers 11 (7), 1040, 2019 | 46 | 2019 |
| Interleukin‐33 is a novel immunosuppressor that protects cancer cells from TIL killing by a macrophage‐mediated shedding mechanism J Wu, Z Chen, SL Wickström, J Gao, X He, X Jing, J Wu, Q Du, M Yang, ... Advanced Science 8 (21), 2101029, 2021 | 28 | 2021 |
| An array of 60,000 antibodies for proteome-scale antibody generation and target discovery Z Wang, Y Li, B Hou, MI Pronobis, M Wang, Y Wang, G Cheng, W Weng, ... Science advances 6 (11), eaax2271, 2020 | 28 | 2020 |
| PMD: A resource for archiving and analyzing protein microarray data Z Xu, L Huang, H Zhang, Y Li, S Guo, N Wang, S Wang, Z Chen, J Wang, ... Scientific Reports 6 (1), 1-5, 2016 | 24 | 2016 |
| Heterogeneity of metabolic vulnerability in imatinib-resistant gastrointestinal stromal tumor WK Huang, J Gao, Z Chen, H Shi, J Yuan, HL Cui, CN Yeh, R Bränström, ... Cells 9 (6), 1333, 2020 | 21 | 2020 |
| Construction of a metabolomics profile of arsenic trioxide effect in gastric carcinoma cell line SGC7901 Z Chen, H Zhang, L Yang, H Jiang, S Guo, Y Li, S Tao Acta Biochim Biophys Sin 48 (5), 474-481, 2016 | 15 | 2016 |
| Phosphodiesterase 4A confers resistance to PGE2‐mediated suppression in CD25+/CD54+ NK cells Z Chen, Y Yang, SY Neo, H Shi, Y Chen, AK Wagner, K Larsson, L Tong, ... EMBO reports 22 (3), e51329, 2021 | 9 | 2021 |
| Tumor MHC class I expression alters cancer-associated myelopoiesis driven by host NK cells SY Neo, X Jing, L Tong, D Tong, J Gao, Z Chen, MC De Los Santos, ... Journal for Immunotherapy of Cancer 10 (10), 2022 | 7 | 2022 |
| Cold snap for cancer: cold-induced brown fat thermogenesis starves tumor growth Z Chen, Y Kang Signal Transduction and Targeted Therapy 8 (1), 10, 2023 | 6 | 2023 |
| CD25bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression Z Chen, L Tong, SY Neo, S Li, J Gao, S Schlisio, A Lundqvist Oncoimmunology 12 (1), 2175517, 2023 | 4 | 2023 |
| A tractable microscopy-and flow cytometry-based method to measure natural killer cell-mediated killing and infiltration of tumor spheroids YA Schwietzer, KH Susek, Z Chen, E Alici, AK Wagner Methods in Cell Biology 178, 43-61, 2023 | 3 | 2023 |
| Renal cell carcinoma escapes NK cell‐mediated immune surveillance through the downregulation of DNAM‐1 L Tong, V Kremer, SY Neo, Y Liu, Y Chen, AK Wagner, Y Yang, Z Chen, ... Cancer Communications 43 (7), 855, 2023 | 2 | 2023 |
| Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis SY Neo, L Tong, J Chong, Y Liu, X Jing, MMS Oliveira, Y Chen, Z Chen, ... Science Translational Medicine 16 (747), eadi2952, 2024 | 1 | 2024 |
| Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease SY Neo, MMS Oliveira, L Tong, Y Chen, Z Chen, S Cismas, N Burduli, ... Journal of Experimental & Clinical Cancer Research 43 (1), 13, 2024 | 1 | 2024 |
| Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic SY Neo, MMS Oliveira, L Tong, Y Chen, Z Chen, S Cismas, N Burduli, ... | | 2024 |
| From Natural to Eximious: Harnessing the Power of Natural Killer Cells Against Solid Tumors Z Chen PQDT-Global, 2021 | | 2021 |
Andreas LundqvistAssociate Professor, Karolinska Institutet 在 ki.se 的电子邮件经过验证
